Response Biomed Corp RPBIF

RE: RE: RE: A profitable quarter!

[dimar66]

What I got out of the conference call is that there has been a lot work done to scope out the market potential.  Aside from the developments of in the US market which are promising both Mexico and the Middle East were mentioned as go to sales opportunities likely to give good results.   Two other areas; India and Brazil are being looked at cautiously.  Management are very concerned to invest the limited resources where there is the best return, meaning some other things may get held up, for example FDA approval of the d-dimer.  The exciting thing about RBM is that it is a small company with a world market, successful development of the business plan could result in huge returns even after all the dilution.  After this last conference call I am more confident about this.